Rising THC Potency Linked to More Cannabis-Related Diagnoses in Germany

Each percentage point increase in THC concentration in German cannabis was associated with a significant increase in cannabis-related psychiatric diagnoses, with a stronger effect in men.

Manthey, Jakob et al.·Drug and alcohol review·2024·Moderate EvidenceObservational
RTHC-05512ObservationalModerate Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Using health insurance data from 2009-2021 and THC data from law enforcement, each one percentage point increase in median THC concentration predicted a higher proportion of cannabis users receiving an F12 diagnosis. The effect was stronger in men (+0.42) than women (+0.17).

Key Numbers

Each 1 percentage point increase in THC associated with +0.42 increase in diagnosis proportion for men and +0.17 for women. Effect significant in all 16 states for men, 15/16 for women.

How They Did This

Ecological study using generalized mixed linear models across 16 German federal states from 2009-2021. Dependent variable was the ratio of insured persons with cannabis-related ICD-10 F12 diagnoses to estimated cannabis users.

Why This Research Matters

As cannabis products get stronger worldwide, this population-level data suggests rising potency may translate directly into more psychiatric diagnoses.

The Bigger Picture

Several countries and states are considering THC potency caps in legal markets. This German data provides population-level support for the idea that higher potency products carry additional health risks.

What This Study Doesn't Tell Us

Ecological study design means individual-level causation cannot be established. THC data from seizures may not represent actual consumer use. Changes in diagnostic practices could confound results.

Questions This Raises

  • ?Would THC potency caps in legal markets reduce the rate of cannabis-related diagnoses?
  • ?Why do men appear more susceptible to the potency-diagnosis relationship than women?

Trust & Context

Key Stat:
Each 1% THC increase: +0.42 diagnosis increase in men, +0.17 in women
Evidence Grade:
Large-scale population data across 16 states and 12 years is compelling, but ecological design introduces uncertainty.
Study Age:
Published in 2024 with data from 2009-2021.
Original Title:
Can the THC concentration predict the number of patients with cannabis-related diagnoses?
Published In:
Drug and alcohol review, 43(7), 1764-1772 (2024)
Database ID:
RTHC-05512

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Does stronger cannabis cause more mental health problems?

This population-level study found that as THC concentrations rose in Germany, so did the proportion of cannabis users receiving psychiatric diagnoses, particularly among men.

Are men more affected by high-potency cannabis?

The data suggest a stronger association between THC concentration and psychiatric diagnoses in men (+0.42) compared to women (+0.17).

Read More on RethinkTHC

Cite This Study

RTHC-05512·https://rethinkthc.com/research/RTHC-05512

APA

Manthey, Jakob; Rosenkranz, Moritz; Jonas, Benjamin; Schwarzkopf, Larissa. (2024). Can the THC concentration predict the number of patients with cannabis-related diagnoses?. Drug and alcohol review, 43(7), 1764-1772. https://doi.org/10.1111/dar.13923

MLA

Manthey, Jakob, et al. "Can the THC concentration predict the number of patients with cannabis-related diagnoses?." Drug and alcohol review, 2024. https://doi.org/10.1111/dar.13923

RethinkTHC

RethinkTHC Research Database. "Can the THC concentration predict the number of patients wit..." RTHC-05512. Retrieved from https://rethinkthc.com/research/manthey-2024-can-the-thc-concentration

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.